These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160 [TBL] [Abstract][Full Text] [Related]
3. The Guillain-Barré syndrome. Fujimura H Handb Clin Neurol; 2013; 115():383-402. PubMed ID: 23931791 [TBL] [Abstract][Full Text] [Related]
4. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. van Doorn PA; Ruts L; Jacobs BC Lancet Neurol; 2008 Oct; 7(10):939-50. PubMed ID: 18848313 [TBL] [Abstract][Full Text] [Related]
5. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital. Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657 [TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome: epidemiology, pathophysiology and management. Kuwabara S Drugs; 2004; 64(6):597-610. PubMed ID: 15018590 [TBL] [Abstract][Full Text] [Related]
8. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome. Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615 [TBL] [Abstract][Full Text] [Related]
9. [Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome]. Orlikowski D; Quijano-Roy S; Sivadon-Tardy V; Raphael JC; Gaillard JL Arch Pediatr; 2006 Dec; 13(12):1561-5. PubMed ID: 17030119 [TBL] [Abstract][Full Text] [Related]
10. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship. Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306 [TBL] [Abstract][Full Text] [Related]
11. [Intensive therapy for patients with Guillian-Barré syndrome]. Buus L; Tønnesen EK Ugeskr Laeger; 2014 Oct; 176(42):. PubMed ID: 25316360 [TBL] [Abstract][Full Text] [Related]
12. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Yuki N Lancet Infect Dis; 2001 Aug; 1(1):29-37. PubMed ID: 11871407 [TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. Prendergast MM; Moran AP J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055 [TBL] [Abstract][Full Text] [Related]
14. Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome. Heikema AP; Islam Z; Horst-Kreft D; Huizinga R; Jacobs BC; Wagenaar JA; Poly F; Guerry P; van Belkum A; Parker CT; Endtz HP Clin Microbiol Infect; 2015 Sep; 21(9):852.e1-9. PubMed ID: 26070960 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Yuki N Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987 [TBL] [Abstract][Full Text] [Related]
20. Association of Campylobacter jejuni infection and GuillainBarré syndrome: a cohort study in the northwest of Iran. Barzegar M; Alizadeh A; Toopchizadeh V; Dastgiri S; Majidi J Turk J Pediatr; 2008; 50(5):443-8. PubMed ID: 19102048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]